CD44 and breast neoplasm: At this stage, we evaluated the contribution of each of the TME-enriched sub-populations, CD44+/CD24low/− or CD44+/β1+, to formation of primary tumors (Figure 8A) and to metastatic spread (further described below) of Luminal-A breast tumor cells.